Bladder cancer Board decisions

The veteran's claim for compensation benefits under the provisions of 38 U.S.C.A. § 1151 is granted, as VA treatment in August 1997 resulted in a bladder tumor that was not promptly addressed.

The Board has remanded the case for additional development and consideration of the claim due to new evidence and changes in the law.

The Board found no evidence to support the claim that VA treatment caused or hastened the veteran's death, and denied the DIC under 38 U.S.C.A. § 1151 (West 1991 & Supp. 2000) for the cause of the veteran's death.

The RO has reopened the claims for left ear hearing loss and migraines, but denied service connection for bladder cancer. The new evidence submitted is sufficient to reopen these claims.

The Board has granted service connection for bladder cancer, depression, and anxiety.

The Board has determined that the appellant's bladder cancer is as likely as not due to Agent Orange exposure in service, and thus grants service connection for residuals of a radical cystoprostatectomy with construction of a permanent ileal conduit for cancer of the bladder. However, there is no competent medical evidence showing prostate cancer, so service connection for prostate cancer secondary to Agent Orange exposure cannot be granted.

The Board granted a 20 percent evaluation for left shoulder disability effective from July 25, 1989. The veteran's claims for service connection for bladder cancer and tuberculosis were found to be well-grounded.

The Board has granted service connection for bladder cancer due to exposure to ionizing radiation in service, as the appellant's claim was reopened on new evidence.

The Board denied the veteran's claim for service connection for bladder cancer due to tobacco use in service, finding that there was no evidence linking his current condition to his smoking during service.

The Board has determined that the claim for service connection for the cause of the veteran's death is not well-grounded because there is no competent medical evidence linking the veteran's metastatic bladder cancer to his period of active service, including any in-service asbestos exposure.

The Board found that the veteran's papillary bladder cancer is not due to disease or injury incurred in service, including exposure to ionizing radiation. The evidence did not show a causal link between the veteran's current condition and his military service.

The Board denied service connection for the cause of the veteran's death due to bladder cancer, finding that there was no medical evidence linking the cause of death (congestive heart failure) to a service-connected condition.

The Board has requested a dose estimate from the Under Secretary for Health due to potential radiation exposure, and the case is being remanded for this purpose.

The medical evidence does not establish that the veteran's bladder cancer was caused by service, including exposure to Agent Orange. The Board finds a preponderance of the evidence against the claim.

The Board found that the veteran's death from bladder cancer was not caused by any incident, injury or disease of active service and denied the claims for service connection for the cause of death and DIC pursuant to 38 U.S.C.A. § 1151.

The Board denied the veteran's claims for service connection for various conditions, including a left eye injury and back injury. The appeals were based on direct evidence rather than presumptive exposure or new and material evidence.

The Board denied an earlier effective date for service connection for urinary bladder cancer due to exposure to ionizing radiation, concluding that the veteran's exposure was less than one rem and unlikely to have caused his condition.

The Board denied the veteran's claims for service connection for bladder cancer and prostate cancer, both of which are presumed to be related to herbicide exposure in Vietnam. The evidence did not support a finding that the cancers were present during or within one year after service, nor was there any competent medical evidence linking the conditions to service.

The Board denied service connection for headaches, fibromyositis, and urinary bladder cancer due to lack of evidence supporting exposure to ionizing radiation during service.

The veteran's bladder and prostate cancer residuals are primarily manifested by urinary frequency, with intervals between daytime voiding of one hour to one hour and twenty minutes and nocturia occurring three times a night. The RO denied an increased evaluation for these disabilities.